A number of studies have reported the existence of different soluble ligands of the NCR released by tumor cells which, upon interaction with NK cell receptors, may cause the blocking and/or modulation of NCR and its associated adaptor signaling molecules, with a consequent inhibition of cytotoxicity [23]. This evidence concerns the gene KLRD1 and neoplasm.